Comparative analysis of antimicrobial drugs recommended by medical and technological documents for the treatment of patients with community-acquired pneumonia
Journal Title: Фармацевтичний журнал - Year 2019, Vol 2, Issue 2
Abstract
Today community-acquired pneumonia remains one of the leading causes of death as a result of infectious diseases. For effective treatment must be guided by such guidelines which would take into account not only recent world experience in the field of antimicrobial therapy but also regional peculiarities of the microbial spectrum and the resistance to pathogens of this nosology. The aim of the work was to conduct a comparative analysis of antimicrobial drugs recommended for the treatment for patients with community-acquired pneumonia. The assortment of major antimicrobial drugs was studied according to the «Pharmstandard» system of the «Morion» company. Also, the research used data of medical and technological documentation of Ukraine, Great Britain, USA. Current the Unified Protocol for the provision of medical care to adult patients with community-acquired pneumonia and the State Medicines Directive offer almost identical antimicrobial drugs and differ only in those that do not have a proof-based basis. Leading international sources recommend a smaller number of drugs whose trade names are sufficient in the domestic market, and pharmacological properties suggest a rational pharmacotherapy of patients with community-acquired pneumonia when using them. Medical and technological documents offer for pharmacotherapy of patients with community-acquired pneumonia more than 20 preparations with more than 500 product names mainly present on the domestic market; in foreign directions a number of drugs (cefaclor, flucloxacillin, temocylin, piperacillin, colistin) are recommended, which are not in the domestic documentation, whose pharmacological properties and price range are rational to have for treatment of patients with community-acquired pneumonia.
Authors and Affiliations
L. V. Iakovlieva, T. O. Bahlai, O. V. Khomenko
Keywords
Related Articles
- EP ID EP559236
- DOI 10.32352/0367-3057.2.19.04
- Views 62
- Downloads 0
Determination of the qualitative and quantitative content of hydroxycinnamic acids in Gentiana Cruciata L. herb
Gentiana cruciata L. is a herbaceous perennial flowering plant in the Gentianaceae family. This plant is widespread in the territory of Ukraine, namely the southern forest areas, forest-steppe and Crimea. Gentiana crucia...
The component composition and antimicrobal activity of the essential oil from inflorescences of Tagetes erecta L.
Tagetes erecta L. is the promising materials for new medicines. The study of composition of Tagetes erecta L. is of great practical and scientific importance. The aim of this scientific work is the determinate of physic...
The development of standard of good pharmacy practice regarding the participation of pharmacists in public health
The change in the focus of healthcare in Ukraine from treatment to preventive medicine is necessary for improvement of medical and demographic situation in the country and the formation of a responsible attitude of citiz...
Research for sele ction the solubilizers for evelopment vaginal gel with thistle’s oil
Gynaecological diseases of bacterial and fungal nature with inflammatory and erosive processes remain a topic issue in the current gynaecology. The main direction of the treatment is the antimicrobial therapy which mainl...
Microscopical analysis of Monarda Fistulosa L. herb
Microscopical characteristic of plants is important for identification of medicinal plant material and establishing parameters of its quality. Determination of diagnostic anatomical features of Monarda fistulosa L. aeria...